Evidence map›Paper›PMID 35082772›Full record

ArticleFrontiers in microbiology2021

Kadi J Horn, Alexander C Jaberi Vivar, Vera Arenas, Sameer Andani, Edward N Janoff, Sarah E Clark

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Review
  3. Association of nasopharyngealMicrobiology spectrum · 2026
    Article
  4. Article
  5. Nasopharyngeal Microbiota in South African Infants With Lower Respiratory Tract Infection: A Nested Case-Control Study of the Drakenstein Child Health Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  6. Microbiome and its Association with Diseases of the Ear, Nose and Pharynx.Endocrine, metabolic & immune disorders drug targets · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. AirwayInfection and immunity · 2025
    Article
  14. Article
  15. Article
  16. Metabolic capabilities are highly conserved among human nasal-associatedbioRxiv : the preprint server for biology · 2024
    Article
  17. Article
  18. Antagonistic Effects ofMicroorganisms · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kadi J HornDepartment of Otolaryngology Head and Neck Surgery, University of Colorado School of Medicine, Aurora, CO, United States.
Alexander C Jaberi VivarDepartment of Otolaryngology Head and Neck Surgery, University of Colorado School of Medicine, Aurora, CO, United States.
Vera ArenasDepartment of Otolaryngology Head and Neck Surgery, University of Colorado School of Medicine, Aurora, CO, United States.
Sameer AndaniDepartment of Otolaryngology Head and Neck Surgery, University of Colorado School of Medicine, Aurora, CO, United States.
Edward N JanoffDivision of Infectious Diseases, University of Colorado School of Medicine, Aurora, CO, United States.
Sarah E ClarkDepartment of Otolaryngology Head and Neck Surgery, University of Colorado School of Medicine, Aurora, CO, United States.
University of Colorado Denver · USWashington University in St. Louis · US

Funding

UC San Diego RAPID Faculty Development Program in Infectious DiseasesR25AI147376 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADRIANA H TREMOULET, Joann Trejo · 2020 to 2026
$2.5M
MARC U-STAR PROGRAM AT WASHINGTON UNIVERSITY IN ST. LOUIST34GM083914 · NIGMS · WASHINGTON UNIVERSITY · PI SKEATH, JAMES BENJAMIN · 2009 to 2020
$2.3M
MARC U-STAR PROGRAM AT WASHINGTON UNIVERSITY IN ST. LOUIST34GM141639 · NIGMS · WASHINGTON UNIVERSITY · PI SKEATH, JAMES BENJAMIN · 2021 to 2024
$1.8M
Bacterial-driven immune suppression in the lungK22AI143922 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CLARK, SARAH E · 2019 to 2021
$310k
NIAID NIH HHS K22 AI143922NIAID NIH HHS R25 AI147376NIGMS NIH HHS T34 GM083914NIGMS NIH HHS T34 GM141639
6 · The paper itself

Abstract

The stability and composition of the airway microbiome is an important determinant of respiratory health. Some airway bacteria are considered to be beneficial due to their potential to impede the acquisition and persistence of opportunistic bacterial pathogens such as

Indexed as

bacterial lipasesCorynebacteriumlung infectionnasopharyngeal colonizationpneumococcuspneumoniaStreptococcus pneumoniae

Identifiers

PMID35082772
PMCPMC8784410
OpenAlexW4205767419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.